Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/19042
Title: | Optimizing anticoagulant therapy in non-Valvular atrial fibrillation |
Authors: | Cassar, Andrew |
Keywords: | Atrial fibrillation Anticoagulants (Medicine) Warfarin Cardiology -- Research |
Issue Date: | 2016 |
Publisher: | Medical Portals Ltd. |
Citation: | Cassar, A. (2016). Optimizing anticoagulant therapy in non-Valvular atrial fibrillation. The Synapse : the Medical Professionals' Network, 15(5), 11-12. |
Abstract: | T he prevalence of atrial fibrillation (AF) is estimated to be around 3% of the population above 20 years of age, and increases with age, hypertension, cardiovascular disease, diabetes and obesity. Besides a 1.5- to 2-fold increase in mortality in people suffering from AF, they also have an increase in morbidity from heart failure and stroke. In fact, 20-30% of all ischaemic strokes are thought to be secondary to AF. The CHA2 DS2 -VASc score is a useful tool to quantify the yearly risk of stroke. One should note that the risk of stroke is independent of whether the AF is paroxysmal, persistent or permanent. |
URI: | https://www.um.edu.mt/library/oar//handle/123456789/19042 |
Appears in Collections: | Scholarly Works - FacM&SMed The Synapse, Volume 15, Issue 5 The Synapse, Volume 15, Issue 5 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
The Synapse 15-5 - A3.pdf | Optimizing anticoagulant therapy in nonValvular atrial fibrillation | 795.04 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.